Deleting that hyperbole was a sensible decision. Having a Pharma Tech employee criticize the very people at the FDA tasked with the review is terrible business decision and immature. This is a public forum, the last thing anyone should want is potential short sellers directing the FDA to that deleted post. What point would it serve to criticize the very body doing a review before any decision is made?
(3)
(0)
Decision Diagnostics Corp (DECN) Stock Research Links